Cargando…
Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has attracted attention as a potential candidate for cancer therapy. However, many primary cancers are resistant to TRAIL, even when combined with standard chemotherapy. The mechanism of TRAIL resistance in cancer cells has not be...
Autores principales: | Lee, Won Hyeok, Han, Myung Woul, Kim, Song Hee, Seong, Daseul, An, Jae Hee, Chang, Hyo Won, Kim, Sang Yoon, Kim, Seong Who, Lee, Jong Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465502/ https://www.ncbi.nlm.nih.gov/pubmed/32784606 http://dx.doi.org/10.3390/cells9081851 |
Ejemplares similares
-
Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer
por: Lee, Won Hyeok, et al.
Publicado: (2022) -
EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
por: Kim, Song-Hee, et al.
Publicado: (2021) -
Posttranscriptional regulation of ILC2 homeostatic function via tristetraprolin
por: Hikichi, Yuki, et al.
Publicado: (2021) -
Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction
por: Lee, Myungjin, et al.
Publicado: (2021) -
Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells
por: Lee, Ji Young, et al.
Publicado: (2013)